These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37147997)

  • 41. Single Nucleotide Polymorphism and mRNA Expression of
    Gołąbek K; Rączka G; Gaździcka J; Miśkiewicz-Orczyk K; Zięba N; Krakowczyk Ł; Hudy D; Asman M; Misiołek M; Strzelczyk JK
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging histopathological parameters in the prognosis of oral squamous cell carcinomas.
    de Morais EF; Almangush A; Salo T; da Silva SD; Kujan O; Coletta RD
    Histol Histopathol; 2024 Jan; 39(1):1-12. PubMed ID: 37310089
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p53 In biopsies of oral squamous cell carcinoma. A comparative study with a malignancy grading system.
    De Araújo VC; Loyola AM; Pinto Júnior DD; Borra RC; De Araújo NS
    Oral Oncol; 1997 Jan; 33(1):5-9. PubMed ID: 9192545
    [TBL] [Abstract][Full Text] [Related]  

  • 44. To evaluate an association between prognostic significance of Moesin with histopathological grading of oral squamous cell carcinoma: A systematic review.
    Bommanavar S; Kanetkar SR; Datkhile KD
    J Oral Maxillofac Pathol; 2023; 27(1):148-161. PubMed ID: 37234334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study.
    Bacchiocchi R; Rubini C; Pierpaoli E; Borghetti G; Procacci P; Nocini PF; Santarelli A; Rocchetti R; Ciavarella D; Lo Muzio L; Fazioli F
    BMC Cancer; 2008 Aug; 8():220. PubMed ID: 18673553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Squamous cell carcinoma of the oral cavity. A review of 176 cases with application of malignancy grading and DNA measurements.
    Tytor M; Olofsson J; Ledin T; Brunk U; Klintenberg C
    Clin Otolaryngol Allied Sci; 1990 Jun; 15(3):235-52. PubMed ID: 2394024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparing prognostic utility between the 8th edition of TNM staging system and the lymph node ratio for oral squamous cell carcinoma.
    Beltramini GA; Belloni LM; Fusco N; Sacconi A; Muti P; Baj A; Bolzoni AR; Giannì AB
    Head Neck; 2021 Oct; 43(10):2876-2882. PubMed ID: 34115912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessing immuno-expression of p53 protein and TP 53 gene amplification in histologically negative surgical margins of oral squamous cell carcinoma patients and normal oral mucosa.
    Kamat MS; Puranik RS; Das Rai AB; Patil BR; Patil S
    Clin Oral Investig; 2022 Oct; 26(10):6235-6243. PubMed ID: 35674840
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elucidating the immunohistochemistry of Nanog: A transcription marker in the oral squamous cell carcinoma with emphasis on its origin as embryonic stem cell.
    Afroze SN; Rao GV; Suri S
    J Oral Maxillofac Pathol; 2022; 26(4):476-482. PubMed ID: 37082043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
    Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
    Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pancytokeratin immunostained tumor buds and cytoplasmic pseudofragments are reliable early predictive variables for regional lymph node metastatic risk assessment of oral squamous cell carcinoma.
    Sowmya SV; Rao RS; Prasad K
    Indian J Dent Res; 2020; 31(6):904-910. PubMed ID: 33753662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Correlation between TNM classification, histological grading and anatomical location in oral squamous cell carcinoma].
    Costa Ade L; Pereira JC; Nunes AA; Arruda Mde L
    Pesqui Odontol Bras; 2002; 16(3):216-20. PubMed ID: 12386682
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ki67 Labelling Index predicts clinical outcome and survival in oral squamous cell carcinoma.
    Gadbail AR; Sarode SC; Chaudhary MS; Gondivkar SM; Tekade SA; Yuwanati M; Patil S
    J Appl Oral Sci; 2021; 29():e20200751. PubMed ID: 33656066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nuclear morphology and histological grading of oral squamous cell carcinoma (OSCC). A morphometric study.
    Giardina C; Serio G; Caniglia DM; Lettini T; Ricco R; Renzulli G; Pesce Delfino V
    Boll Soc Ital Biol Sper; 1994; 70(10-11):271-9. PubMed ID: 7702831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of proliferating cell nuclear antigen (PCNA) expression at the invading front of oral squamous cell carcinoma.
    Lu EM; Ratnayake J; Rich AM
    BMC Oral Health; 2019 Oct; 19(1):233. PubMed ID: 31672124
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histopathologic grading and its relationship with outcome in oral tongue squamous cell carcinoma.
    Silva LABD; Lopes MLDS; Sá MC; de Almeida Freitas R; Coletta RD; da Silveira EJD; da Costa Miguel MC
    J Oral Pathol Med; 2021 Feb; 50(2):183-190. PubMed ID: 33151566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Knowing the unknown in oral squamous cell carcinoma: An observational study.
    Gupta S; Kamboj M; Narwal A
    J Cancer Res Ther; 2020; 16(3):494-499. PubMed ID: 32719256
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Staging and grading of oral squamous cell carcinoma: An update.
    Almangush A; Mäkitie AA; Triantafyllou A; de Bree R; Strojan P; Rinaldo A; Hernandez-Prera JC; Suárez C; Kowalski LP; Ferlito A; Leivo I
    Oral Oncol; 2020 Aug; 107():104799. PubMed ID: 32446214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
    Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
    Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.